4[1]Khoschrorur G,Aure T,Lanzer G,et al.The determination of metabolite and its meaning for immumosuppressive cyclosprin therapy[J].Angiology,1998,49(1):307-310.
6[5]Tricottet V,Reynes M,Vemilkt L,et al.Attempt at ptotonic ultrastractural immuohistochemieal localization of CSA in rat kidney and liver[J].Transplant proc,1987,19(16):1221-1226.
7[6]Palomero J,Galan AI,Munoz ME,et al.S-adenosyl-methionine protects against intrabiliary glutathione degradation induced by long-term administration of cyclosporin A in the rat[J].Toxicology,2004,201(13):239-245.
8[7]Duruibe VA,Okonmah A,Blyden GT.Effect of cyclosporin on rat liver and k idney glutath ionecontent[J].Pharmacology,1989,39 (4):205-212.
9[8]Kumar D,Tandon RK.Use of ursodeoxycholic acid in liver diseases[J].Gas2 troenterol Hepatol,2001,16 (1):3-14.
10[9]Rodrigues CM,Fan G,Ma X,et al.A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation[J].Clin Invest,1998,101 (12):2790-2799.
